13F

GMED GLOBUS MEDICAL INC - A

2026Q1 · CUSIP 379577208 · Sector: Healthcare & Biotech

Lit · Institutions accelerating in
Holders
599
Δ holders QoQ
+38
Breadth percentile
Top 7%
Whale holders
217
Δ whales
+8
Inst. holding value
$9.2B
New positions
104
Closed positions
66
Price momentum (1Q)
-11.3%
Put / Call
5/7

Breadth history (34 quarters)

2018Q1: Δ+17 · h=279 2018Q2: Δ+12 · h=291 2018Q3: Δ+20 · h=311 2018Q4: Δ-9 · h=302 2019Q1: Δ-31 · h=271 2019Q2: Δ-12 · h=259 2019Q3: Δ+8 · h=267 2019Q4: Δ+40 · h=307 2020Q1: Δ-34 · h=273 2020Q2: Δ+46 · h=319 2020Q3: Δ+24 · h=343 2020Q4: Δ+6 · h=349 2021Q1: Δ-6 · h=343 2021Q2: Δ+11 · h=354 2021Q3: Δ+33 · h=387 2021Q4: Δ-15 · h=372 2022Q1: Δ+3 · h=375 2022Q2: Δ-14 · h=361 2022Q3: Δ+9 · h=370 2022Q4: Δ+21 · h=391 2023Q1: Δ+1 · h=392 2023Q2: Δ-10 · h=382 2023Q3: Δ+50 · h=432 2023Q4: Δ-24 · h=408 2024Q1: Δ+28 · h=436 2024Q2: Δ+15 · h=451 2024Q3: Δ-1 · h=450 2024Q4: Δ+53 · h=503 2025Q1: Δ+16 · h=519 2025Q2: Δ-34 · h=485 2025Q3: Δ+2 · h=487 2025Q4: Δ+74 · h=561 2026Q1: Δ+38 · h=599 2018Q1: holders=279 2018Q2: holders=291 2018Q3: holders=311 2018Q4: holders=302 2019Q1: holders=271 2019Q2: holders=259 2019Q3: holders=267 2019Q4: holders=307 2020Q1: holders=273 2020Q2: holders=319 2020Q3: holders=343 2020Q4: holders=349 2021Q1: holders=343 2021Q2: holders=354 2021Q3: holders=387 2021Q4: holders=372 2022Q1: holders=375 2022Q2: holders=361 2022Q3: holders=370 2022Q4: holders=391 2023Q1: holders=392 2023Q2: holders=382 2023Q3: holders=432 2023Q4: holders=408 2024Q1: holders=436 2024Q2: holders=451 2024Q3: holders=450 2024Q4: holders=503 2025Q1: holders=519 2025Q2: holders=485 2025Q3: holders=487 2025Q4: holders=561 2026Q1: holders=599 -74 -37 +0 +37 +74 233431629 18Q119Q120Q121Q122Q123Q124Q125Q126Q1 Δ holders (bar) Holders (line)

Past Lit Events & Aftermath 16 lit events

Period Percentile Next-1Q return Next-2Q return
2026Q1 Top 7%
2025Q4 Top 6% -11.3%
2025Q1 Top 15% +0.2% +37.0%
2024Q4 Top 9% -28.0% -27.9%
2024Q2 Top 18% +16.1% +20.4%
2024Q1 Top 10% +8.7% +25.9%
2023Q3 Top 1% +17.2% +43.4%
2022Q4 Top 19% -6.2% -9.1%

Options Sentiment

Put holders
5
QoQ: -5
Call holders
7
QoQ: -6

See methodology →

Fundamentals

PE (TTM)
17.5
EPS (TTM)
$4.28
EPS YoY
+219.4%
Revenue (TTM)
$3.1B
Revenue YoY
+23.5%
Quarterly Revenue & EPS (4Y)
2022-06-30: $264M 2022-09-30: $254M 2022-12-31: $274M 2023-03-31: $277M 2023-06-30: $292M 2023-09-30: $384M 2023-12-31: $617M 2024-03-31: $607M 2024-06-30: $630M 2024-09-30: $626M 2024-12-31: $657M 2025-03-31: $598M 2025-06-30: $745M 2025-09-30: $769M 2025-12-31: $826M 2026-03-31: $760M 2022-06-30: EPS 0.53 2022-09-30: EPS 0.47 2022-12-31: EPS 0.48 2023-03-31: EPS 0.48 2023-06-30: EPS 0.57 2023-09-30: EPS 0.01 2023-12-31: EPS 0.01 2024-03-31: EPS -0.05 2024-06-30: EPS 0.23 2024-09-30: EPS 0.38 2024-12-31: EPS 0.19 2025-03-31: EPS 0.54 2025-06-30: EPS 1.49 2025-09-30: EPS 0.88 2025-12-31: EPS 1.01 2026-03-31: EPS 0.90 0M 413M 826M $M -0.06 0.79 1.64 20222023202420252026 Revenue EPS

Quarterly figures; EPS split-adjusted, early quarters hidden when not calibrable

P/E (TTM) over time
4Y median 30 2023-03-31: PE 292023-06-30: PE 28.12023-09-30: PE 302023-12-31: PE 50.32024-03-31: PE 119.32024-06-30: PE 349.32024-09-30: PE 142.32024-12-31: PE 111.92025-03-31: PE 45.72025-06-30: PE 23.32025-09-30: PE 27.22025-12-31: PE 22.52026-03-31: PE 17.9 16 191 367 20222023202420252026

P/E = close 47 days after quarter-end (filing date) ÷ TTM EPS then; loss quarters hidden

As of 2026-03-31 · SEC filings (XBRL)